Category: 2021

Five First Growths of Bordeaux

A tasty great investment

The Exposition Universelle of 1855, held in Paris, attracted millions of visitors, who passed through grand halls where the latest works of industry and culture were on display. In the 19th century, France was recognized as the world’s finest producer of wine — so there was no question that wines would be offered for sampling. The question was how thewines would be exhibited.

 Bordeaux’s wines (commonly referred to as clarets) were already known around the world, particularly in England, whose wealthier classes had been importing them in mass quantities for centuries. So, it was no surprise that the country’s new Emperor, Napoleon III, ordered a classification drawn up of Bordeaux’s best wines. The wines were ranked by reputation and price, with an emphasis on the latter. The result was The Bordeaux Wine Official Classification of 1855.

Phizer Inc. ~ 12-03-2021

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare.

Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.

Moderna, Inc. (MRNA) 9/22/21 9:54 AM

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.

BioNTech SE (BNTX) 9/22/21 9:30 AM

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases.

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

CoreCard Software, Inc.

Shares of Intelligent Systems INS, +0.57%  have been on an absolute tear lately. Shares are up more than 150% year-to-date since Jan. 1, and more than 500% in the last year! That’s because this yet-unprofitable small-cap stock has seen equally impressive revenue growth thanks to its payment processing technology.

CoreCard is a leading issuer-processor and provider of card management and transaction processing systems. CoreCard offers an array of account management and system of record solutions to support the complex requirements of the evolving global financial services industry.

The CoreCard platform provides the market’s most feature-rich design for card processing and managing accounts. The platform supports a full range of card products including prepaid/stored-value, fleet, revolving credit, loans, pay-day lending, debit, commercial, government, healthcare and private-label cards.